CLOS
PFE icon

Compagnie Lombard Odier SCmA’s Pfizer PFE Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,000
Closed -$33K – 706
2021
Q3 		$33K Buy
+14,000
New +$620K ﹤0.01% 529

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Compagnie Lombard Odier SCmA's PFE Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA reduced its Pfizer (PFE) stake by 1.3% in Q1 2026, selling an estimated $137K and leaving 381,061 shares worth $10.7M. The position accounts for 0.13% of the portfolio, ranked #83.

Compagnie Lombard Odier SCmA first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $18.8M in Q4 2015. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Compagnie Lombard Odier SCmA held 381,061 shares of Pfizer worth $10.7M as of Q1 2026.
  • Compagnie Lombard Odier SCmA sold 5,164 Pfizer shares in Q1 2026, an estimated $137K.
  • Pfizer made up 0.13% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #83 holding.
  • Compagnie Lombard Odier SCmA first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
  • Compagnie Lombard Odier SCmA's Pfizer position peaked at $18.8M in Q4 2015.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.